Neoprobe Corporation Retains Makovsky + Company for Strategic Communications & Investor Relations Program
DUBLIN, Ohio--(BUSINESS WIRE)--Neoprobe Corporation (OTCBB:NEOP), a diversified developer of innovative biomedical surgical oncology products, today announced that it has retained Makovsky + Company, a leading global, independent public relations, investor relations and branding firm headquartered in New York City, for the development of a strategic communications and investor relations program.